Breaking News Instant updates and real-time market news.

IMGN

ImmunoGen

$4.67 /

-0.04 (-0.85%)

20:51
01/22/20
01/22
20:51
01/22/20
20:51

ImmunoGen 21.325M share Spot Secondary priced at $4.25

The deal size was increased to $90.6M from $75M. Jefferies, Cowen and William Blair are acting as joint book running managers for the offering.

  • 21

    Jan

IMGN ImmunoGen
$4.67 /

-0.04 (-0.85%)

12/17/19 H.C. Wainwright
ImmunoGen price target hiked to $9 after 'compelling' advance at H.C. Wainwright
09/29/19 Piper Sandler
Biomarker screening reason for ImmunoGen FORWARD I failure, says Piper Jaffray
05/15/19 H.C. Wainwright
H.C. Wainwright says 'wrong again' about ImmunoGen, lowers price target to $4
05/15/19 Guggenheim
ImmunoGen downgraded to Neutral from Buy at Guggenheim

TODAY'S FREE FLY STORIES

Hot Stocks
BridgeBio appoints Ronald Daniels to board of directors » 07:38
02/24/20
02/24
07:38
02/24/20
07:38
BBIO

BridgeBio

$36.09 /

+1.09 (+3.11%)

BridgeBio Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Deere price target raised to $210 from $204 at Credit Suisse » 07:38
02/24/20
02/24
07:38
02/24/20
07:38
DE

Deere

$177.42 /

+11.62 (+7.01%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Primoris announces resignation of director Brian Pratt » 07:37
02/24/20
02/24
07:37
02/24/20
07:37
PRIM

Primoris

$23.08 /

+0.65 (+2.90%)

Primoris Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Argenx price target raised to $201 from $164 at Guggenheim » 07:36
02/24/20
02/24
07:36
02/24/20
07:36
ARGX

Argenx

$161.48 /

+0.38 (+0.24%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett says Berkshire 80% in equities, 20% in cash » 07:36
02/24/20
02/24
07:36
02/24/20
07:36
BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffett is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Enochian Biosciences announces FDA INTERACT meeting date for potential HIV cure » 07:36
02/24/20
02/24
07:36
02/24/20
07:36
ENOB

Enochian Biosciences

$3.36 /

-0.09 (-2.61%)

Enochian Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
CEL-SCI management to meet with SunTrust » 07:35
02/24/20
02/24
07:35
02/24/20
07:35
CVM

CEL-SCI

$16.33 /

-0.66 (-3.88%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Berkshire shares won't be top 15% performer in next 15 years, Buffett says » 07:35
02/24/20
02/24
07:35
02/24/20
07:35
BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

Warren Buffett, while…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Unusual call flow in option market yesterday » 07:35
02/24/20
02/24
07:35
02/24/20
07:35
GLUU

Glu Mobile

$7.84 /

+0.42 (+5.66%)

, MIK

Michaels

$5.23 /

+0.03 (+0.58%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
eHealth price target raised to $179 from $145 at Credit Suisse » 07:35
02/24/20
02/24
07:35
02/24/20
07:35
EHTH

eHealth

$131.37 /

+2.255 (+1.75%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tactile Systems announces denial of motion to dismiss qui tam complaint » 07:34
02/24/20
02/24
07:34
02/24/20
07:34
TCMD

Tactile Systems

$60.05 /

-2.95 (-4.68%)

Tactile Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cronos Group to delay Q4, FY19 earnings release, conference call » 07:33
02/24/20
02/24
07:33
02/24/20
07:33
CRON

Cronos Group

$7.15 /

-0.19 (-2.59%)

Cronos Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Morgan Stanley upgrades Keurig Dr Pepper to Equal Weight after underperformance » 07:33
02/24/20
02/24
07:33
02/24/20
07:33
KDP

Keurig Dr Pepper

$29.51 /

+0.21 (+0.72%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aeglea BioTherapeutics expects capital to fund operations through 1Q21 » 07:33
02/24/20
02/24
07:33
02/24/20
07:33
AGLE

Aeglea BioTherapeutics

$7.84 /

-0.35 (-4.27%)

As of December 31, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Brookfield Business Partners management to meet with CIBC » 07:32
02/24/20
02/24
07:32
02/24/20
07:32
BBU

Brookfield Business Partners

$45.41 /

-0.35 (-0.76%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Aeglea BioTherapeutics reports FY19 EPS ($2.45), consensus ($2.48) » 07:32
02/24/20
02/24
07:32
02/24/20
07:32
AGLE

Aeglea BioTherapeutics

$7.84 /

-0.35 (-4.27%)

"Our accomplishments…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Pinnacle West price target raised to $106 from $97 at Credit Suisse » 07:32
02/24/20
02/24
07:32
02/24/20
07:32
PNW

Pinnacle West

$103.57 /

+2.335 (+2.31%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Thermo Fisher price target raised to $370 from $340 at Argus » 07:32
02/24/20
02/24
07:32
02/24/20
07:32
TMO

Thermo Fisher

$334.84 /

-1.04 (-0.31%)

Argus analyst David Toung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Texas Pacific Land Trust announces $6.00 per sub-share special dividend » 07:32
02/24/20
02/24
07:32
02/24/20
07:32
TPL

Texas Pacific Land Trust

$767.10 /

-13.45 (-1.72%)

Texas Pacific Land Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
iStar reports Q4 adjusted EPS (44c), may not compare to consensus 2c  07:31
02/24/20
02/24
07:31
02/24/20
07:31
STAR

iStar

$16.43 /

+0.325 (+2.02%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Aspen Group management to meet with Roth Capital » 07:29
02/24/20
02/24
07:29
02/24/20
07:29
ASPU

Aspen Group

$10.11 /

+0.25 (+2.54%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
E-Trade downgraded to Neutral from Buy at Goldman Sachs » 07:28
02/24/20
02/24
07:28
02/24/20
07:28
ETFC

E-Trade

$53.23 /

-1.22 (-2.24%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
AAR Corp. management to meet with SunTrust » 07:26
02/24/20
02/24
07:26
02/24/20
07:26
AIR

AAR Corp.

$45.74 /

+0.9 (+2.01%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Immunovant initiated with an Outperform at SVB Leerink » 07:24
02/24/20
02/24
07:24
02/24/20
07:24
IMVT

Immunovant

$15.51 /

-0.19 (-1.21%)

SVB Leerink initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WeedMD engages KCSA for investor relations services » 07:24
02/24/20
02/24
07:24
02/24/20
07:24
WDDMF

WeedMD

$0.00 /

+ (+0.00%)

WeedMD announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.